{
    "clinical_study": {
        "@rank": "129493", 
        "acronym": "STEP", 
        "biospec_descr": {
            "textblock": "Blood and Urine specimens"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "Esophageal squamous cell cancer (ESCC) is common in the developing world, and is the leading\n      cancer diagnosis at Tenwek Hospital in southwestern Kenya. The investigators long-term goal\n      is to understand the pathogenesis and risk factors for ESCC in Kenya, and to establish\n      effective screening and prevention programs. The investigators hypothesize that asymptomatic\n      esophageal squamous dysplasia (ESD) is common in their region, and the current protocol is\n      designed to determine the prevalence of ESD in residents of southwestern Kenya."
        }, 
        "brief_title": "Study of Esophageal Squamous Dysplasia Prevalence at Tenwek Hospital", 
        "completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Esophageal Dysplasia", 
        "detailed_description": {
            "textblock": "The prevalence of esophageal squamous dysplasia will be determined after evaluating\n      pathology reports from unstained lesions and normal biopsies after staining with Lugol's\n      iodine."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age \u2265 20 years\n\n          -  No dysphagia (subjects will be asked \"do you have trouble swallowing food or water?\n             Do they get stuck inside after you swallow?\" in their primary language\n\n        Exclusion Criteria:\n\n          -  Cardiac, respiratory, or metabolic disease that would increase the risk of endoscopy:\n             history of myocardial infarction, arrhythmias, chronic obstructive pulmonary disease,\n             diabetes, allergy to lidocaine.\n\n          -  Unable or unwilling to provide informed consent."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "79 Years", 
            "minimum_age": "20 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Adult Asymptomatic subjects residing within a 50 kilometer radius of Tenwek Hospital"
            }
        }, 
        "enrollment": {
            "#text": "305", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01981876", 
            "org_study_id": "P172/06/2010"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Dysplasia", 
            "Esophageal Squamous Cell Carcinoma"
        ], 
        "lastchanged_date": "November 5, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Bomet", 
                    "country": "Kenya", 
                    "state": "Riftvalley", 
                    "zip": "20400"
                }, 
                "name": "Tenwek Hospital"
            }
        }, 
        "location_countries": {
            "country": "Kenya"
        }, 
        "number_of_groups": "1", 
        "official_title": "Study of Esophageal Squamous Dysplasia Prevalence at Tenwek Hospital", 
        "other_outcome": [
            {
                "description": "An analysis of dysplasia rates in each percentile age group", 
                "measure": "Distribution of dysplasia rate by age", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "description": "Distribution of unstained lesions on the esophagus based on their anatomic location after staining with lugol's iodine", 
                "measure": "Distribution of unstained lesions on the esophagus by anatomic location", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "description": "Distribution of dysplasia rates by sex of the subjects", 
                "measure": "Distribution of dysplasia rate by gender", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }
        ], 
        "overall_official": [
            {
                "affiliation": "Tenwek Hospital", 
                "last_name": "Michael M Mwachiro, MBChB", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Tenwek Hospital", 
                "last_name": "Russ E White, MD", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Kenya: Ethical Review Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Percentage rate of subjects with Esophageal Squamous dysplasia calculated as Prevalence", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01981876"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "percentage of subjects with severe esophageal squamous dysplasia calculated as a prevalence", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "measure": "percentage of subjects with moderate esophageal squamous dysplasia calculated as a prevalence", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "measure": "percentage of subjects with mild esophageal squamous dysplasia calculated as a prevalence", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }
        ], 
        "source": "Tenwek Hospital", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Kenyatta National Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Mayo Clinic", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "AORTIC", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Tenwek Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2010", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "November 2013"
    }
}